A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Please provide your email address to receive an email when new articles are posted on . The next-generation Cologuard test was significantly more likely to detect cancer (94% vs. 67%) compared with ...
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity Findings underscore strength of Natera’s technology for early ...
MADISON, Wis., Oct. 22, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the pivotal ...
Conclusions Symptoms, the SAC and the m-BESS have poor test-retest reliability. Symptoms have reasonable sensitivity and specificity for concussion but are subjective. The 3-word SAC and m-BESS are ...